help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, D. W.
Right arrow Articles by Hedley-Whyte, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, D. W.
Right arrow Articles by Hedley-Whyte, E. T.

American Journal of Pathology, Vol 135, 329-338, Copyright © 1989 by American Society for Investigative Pathology

REGULAR ARTICLES

Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study

DW Hsu, PN Riskind and ET Hedley-Whyte
C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Boston 02114.

Recent evidence indicates that vasoactive intestinal peptide (VIP) may be involved in normal pituitary function. Immunocytochemistry was used to localize VIP in human biopsied pituitary adenomas and postmortem anterior pituitary glands. Paraffin sections were immunostained for VIP with the avidin-biotin-peroxidase technique. Strong VIP-like immunoreactivity (VIP-LI) was observed in 16 of 17 prolactinomas, 12 of 14 growth hormone-secreting tumors associated with acromegaly, four of 12 ACTH-secreting tumors, and 14 of 18 nonfunctioning pituitary adenomas. In most cases, VIP was colocalized with the classical pituitary hormones. Six of the 18 nonfunctioning tumors had no demonstrable hormone immunoreactivity; five of these stained strongly for VIP, whereas one was negative. Of 18 normal anterior pituitaries, 12 showed strong diffuse staining for VIP throughout the gland. One pituitary with VIP-LI came from an individual who had undergone pituitary stalk transection. Double-immunoenzyme labeling and immunoelectron microscopy demonstrated VIP-LI in many lactotrophs, scattered thyrotrophs, corticotrophs, and in an occasional gonadotroph. These results suggest the following: 1) VIP is present in more than one cell type in normal and adenomatous human pituitaries; and 2) VIP may be involved in the function and development of pituitary tumors.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
K. Iino, H. Sasano, Y. Oki, N. Andoh, R.-W. Shin, T. Kitamoto, K. Totsune, K. Takahashi, H. Suzuki, H. Nagura, et al.
Urocortin Expression in Human Pituitary Gland and Pituitary Adenoma
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3842 - 3850.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Society for Investigative Pathology.